William F. Rencher - 15 Feb 2022 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Former Section 16 officer
Signature
/s/ Alex Levit, Attorney-in-Fact
Issuer symbol
CNTX
Transactions as of
15 Feb 2022
Net transactions value
$0
Form type
4
Filing time
17 Feb 2022, 15:48:55 UTC
Previous filing
17 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +8,000 $0.000000 8,000 15 Feb 2022 Common Stock 8,000 $2.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

William F. Rencher is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The stock option vests in equal installments with 1/10th vesting on the date of this grant and each grant thereafter occurring on the last day of each calendar month until fully vested on October 31, 2022.